Pages that link to "Q48465200"
Jump to navigation
Jump to search
The following pages link to Huntington disease (Q48465200):
Displaying 50 items.
- Ubiquitin-proteasome system involvement in Huntington's disease (Q21129327) (← links)
- Evaluation of Dimebon in cellular model of Huntington's disease (Q21202838) (← links)
- Cell therapy in Huntington disease (Q22305670) (← links)
- Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1 (Q24310249) (← links)
- Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder (Q24626017) (← links)
- Intracellular degradation of misfolded proteins in polyglutamine neurodegenerative diseases (Q24644954) (← links)
- Neuroprotective effects of inositol 1,4,5-trisphosphate receptor C-terminal fragment in a Huntington's disease mouse model (Q24647950) (← links)
- Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease (Q24657764) (← links)
- Inactivation of the Huntington's disease gene (Hdh) impairs anterior streak formation and early patterning of the mouse embryo (Q24813199) (← links)
- Corticostriatal Dysfunction in Huntington's Disease: The Basics (Q26738379) (← links)
- Palmitoylation in Alzheimer's disease and other neurodegenerative diseases (Q26747019) (← links)
- Subcellular Clearance and Accumulation of Huntington Disease Protein: A Mini-Review (Q26752720) (← links)
- The P42 peptide and Peptide-based therapies for Huntington's disease (Q26764930) (← links)
- Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine (Q26768648) (← links)
- Neural and mesenchymal stem cells in animal models of Huntington's disease: past experiences and future challenges (Q26775932) (← links)
- Resveratrol: A Focus on Several Neurodegenerative Diseases (Q26800952) (← links)
- Transgenic animal models for study of the pathogenesis of Huntington's disease and therapy (Q26849677) (← links)
- PGC-1α, mitochondrial dysfunction, and Huntington's disease (Q27001671) (← links)
- Modeling Huntington's disease with induced pluripotent stem cells (Q27004209) (← links)
- Physical exercise-induced adult neurogenesis: a good strategy to prevent cognitive decline in neurodegenerative diseases? (Q27012489) (← links)
- Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease (Q27015687) (← links)
- Genetics and neuropathology of Huntington's disease (Q27023050) (← links)
- Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes (Q27305777) (← links)
- N17 Modifies mutant Huntingtin nuclear pathogenesis and severity of disease in HD BAC transgenic mice (Q27306025) (← links)
- Secondary Structure of Huntingtin Amino-Terminal Region (Q27657408) (← links)
- Beta conformation of polyglutamine track revealed by a crystal structure of Huntingtin N-terminal region with insertion of three histidine residues (Q27676093) (← links)
- The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington's disease (Q28072937) (← links)
- Expression of mutant huntingtin blocks exocytosis in PC12 cells by depletion of complexin II (Q28179222) (← links)
- Normal huntingtin function: an alternative approach to Huntington's disease (Q28281904) (← links)
- Huntington's disease (Q28284355) (← links)
- Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis (Q28386202) (← links)
- Mitochondrial targeting of XJB-5-131 attenuates or improves pathophysiology in HdhQ150 animals with well-developed disease phenotypes (Q28386769) (← links)
- Autophagy Activation by Transcription Factor EB (TFEB) in Striatum of HDQ175/Q7 Mice. (Q28392951) (← links)
- Aggregation of polyQ proteins is increased upon yeast aging and affected by Sir2 and Hsf1: novel quantitative biochemical and microscopic assays (Q28483615) (← links)
- Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice (Q28510296) (← links)
- Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats (Q28533959) (← links)
- Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington's disease (Q28587809) (← links)
- Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease (Q28588314) (← links)
- Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease (Q28589793) (← links)
- NMDA receptor function and NMDA receptor-dependent phosphorylation of huntingtin is altered by the endocytic protein HIP1 (Q28591926) (← links)
- Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease (Q28592714) (← links)
- Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease (Q28594357) (← links)
- p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death (Q29547297) (← links)
- Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain (Q29614725) (← links)
- Measuring the thickness of the human cerebral cortex from magnetic resonance images (Q29615080) (← links)
- Huntingtin bodies sequester vesicle-associated proteins by a polyproline-dependent interaction. (Q30164317) (← links)
- The Allure of High-Risk Rewards in Huntington's disease (Q30277857) (← links)
- Serine 421 regulates mutant huntingtin toxicity and clearance in mice. (Q30355064) (← links)
- An Intein-based Strategy for the Production of Tag-free Huntingtin Exon 1 Proteins Enables New Insights into the Polyglutamine Dependence of Httex1 Aggregation and Fibril Formation (Q30385936) (← links)
- Disruption of response inhibition circuits in prodromal Huntington disease (Q30403689) (← links)